22-50674638-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_001372044.2(SHANK3):c.222G>T(p.Ala74=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000593 in 994,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00033 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000013 ( 0 hom. )
Consequence
SHANK3
NM_001372044.2 synonymous
NM_001372044.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.335
Genes affected
SHANK3 (HGNC:14294): (SH3 and multiple ankyrin repeat domains 3) This gene is a member of the Shank gene family. Shank proteins are multidomain scaffold proteins of the postsynaptic density that connect neurotransmitter receptors, ion channels, and other membrane proteins to the actin cytoskeleton and G-protein-coupled signaling pathways. Shank proteins also play a role in synapse formation and dendritic spine maturation. Mutations in this gene are a cause of autism spectrum disorder (ASD), which is characterized by impairments in social interaction and communication, and restricted behavioral patterns and interests. Mutations in this gene also cause schizophrenia type 15, and are a major causative factor in the neurological symptoms of 22q13.3 deletion syndrome, which is also known as Phelan-McDermid syndrome. Additional isoforms have been described for this gene but they have not yet been experimentally verified. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 22-50674638-G-T is Benign according to our data. Variant chr22-50674638-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1215997.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BP7
Synonymous conserved (PhyloP=-0.335 with no splicing effect.
BS2
High AC in GnomAd4 at 48 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SHANK3 | NM_001372044.2 | c.222G>T | p.Ala74= | synonymous_variant | 3/25 | ENST00000710353.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SHANK3 | ENST00000692848.1 | c.-4G>T | 5_prime_UTR_variant | 1/10 | |||||
SHANK3 | ENST00000414786.7 | n.224G>T | non_coding_transcript_exon_variant | 1/23 | 5 | ||||
SHANK3 | ENST00000673971.2 | c.-4G>T | 5_prime_UTR_variant, NMD_transcript_variant | 1/23 |
Frequencies
GnomAD3 genomes AF: 0.000333 AC: 48AN: 143946Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
48
AN:
143946
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000129 AC: 11AN: 850734Hom.: 0 Cov.: 28 AF XY: 0.0000126 AC XY: 5AN XY: 395456
GnomAD4 exome
AF:
AC:
11
AN:
850734
Hom.:
Cov.:
28
AF XY:
AC XY:
5
AN XY:
395456
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000333 AC: 48AN: 143998Hom.: 0 Cov.: 29 AF XY: 0.000314 AC XY: 22AN XY: 70016
GnomAD4 genome
AF:
AC:
48
AN:
143998
Hom.:
Cov.:
29
AF XY:
AC XY:
22
AN XY:
70016
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2020 | The c.-4G>T variant is located in the 5' untranslated region (5’ UTR) of the SHANK3 gene. This variant results from a G to T substitution 4 bases upstream from the first translated codon. This nucleotide position is not well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 18, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at